Novavax
NVAX
265 hedge funds and large institutions have $1.1B invested in Novavax in 2026 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 77 increasing their positions, 87 reducing their positions, and 31 closing their positions.
35% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 31
15% more capital invested
Capital invested by funds: $960M → $1.1B (+$145M)
3% more funds holding
Funds holding: 258 → 265 (+7)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.22% less ownership
Funds ownership: 71.56% → 71.34% (-0.22%)
11% less repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 87
18% less call options, than puts
Call options by funds: $55.7M | Put options by funds: $67.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$31.1M |
| 2 |
State Street
Boston,
Massachusetts
|
+$24.8M |
| 3 |
Goldman Sachs
New York
|
+$14.3M |
| 4 |
TCMG
TSP Capital Management Group
Summit,
New Jersey
|
+$12.7M |
| 5 |
BlackRock
New York
|
+$9.88M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
-$28.9M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$23.4M |
| 3 |
Millennium Management
New York
|
-$18.7M |
| 4 |
D.E. Shaw & Co
New York
|
-$18.4M |
| 5 |
Barclays
London,
United Kingdom
|
-$9.41M |
NVAX Hedge Fund Activity: Q2 2026 in Review
265 institutional investors reported a position in Novavax (NVAX) for Q2 2026, worth a combined $1.1B — up 15% from $960M a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new NVAX positions and 31 closed out — a net gain of 11 holders — while 77 added to existing stakes and 87 trimmed.
The largest buyer was Two Sigma Investments, adding an estimated $31.1M. The largest seller was Bank of America, cutting an estimated $28.9M.
- 265 institutional investors held Novavax (NVAX) as of Q2 2026, up from 258 in Q1 2026.
- Funds reported $1.1B of Novavax stock for Q2 2026, up 15% quarter-over-quarter.
- 42 funds opened new Novavax positions in Q2 2026 and 31 closed out, a net change of +11 holders.
- The largest Novavax buyer in Q2 2026 was Two Sigma Investments, an estimated $31.1M added.
- The largest Novavax seller in Q2 2026 was Bank of America, an estimated $28.9M sold.
Based on aggregated 13F filings for Q2 2026.